<DOC>
	<DOCNO>NCT00560950</DOCNO>
	<brief_summary>The purpose study determine revaccination Pneumococcal Vaccine well tolerate produce immune response older adult .</brief_summary>
	<brief_title>Revaccination With PNEUMOVAX ( TM ) 23 Older Adults ( V110-007 )</brief_title>
	<detailed_description>This study extension study ( V110-007-10 ) meet requirement post clinicaltrials.gov . The original study ( V110-007-00 ) complete 2004 meet criterion registration .</detailed_description>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Postmenopausal negative urine pregnancy test female No fever day vaccination History allergy vaccine component History pneumococcal disease Received live virus vaccination within 4 week prior study start Received inactivated vaccination within 7 day prior study start Received blood product within 5 month prior study start Participated investigational drug vaccine study past 30 day Received immunosuppressive therapy Patient immune deficiency</criteria>
	<gender>All</gender>
	<minimum_age>59 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>